e-learning
resources
Munich 2006
Sunday 03.09.2006
Clinical features of interstitial lung disease
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Anti-endothelial cell antibodies in patients with idiopathic nonspecific interstitial pneumonia
T. Matsui, N. Inui, T. Fujisawa, N. Enomoto, T. Suda, K. Chida, Y. Miyamoto, N. Takai (Hamamatsu, Japan)
Source:
Annual Congress 2006 - Clinical features of interstitial lung disease
Session:
Clinical features of interstitial lung disease
Session type:
Electronic Poster Discussion
Number:
1776
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
T. Matsui, N. Inui, T. Fujisawa, N. Enomoto, T. Suda, K. Chida, Y. Miyamoto, N. Takai (Hamamatsu, Japan). Anti-endothelial cell antibodies in patients with idiopathic nonspecific interstitial pneumonia. Eur Respir J 2006; 28: Suppl. 50, 1776
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
Predictive indexes in prolonged weaning of mechanical ventilation due to tracheostomy in patients with COVID-19 pneumonia
Panel discussion on acute decompensated pulmonary hypertension
Related content which might interest you:
Myositis-specific antibodies in a cohort of idiopathic interstitial pneumonias with suggestive morphologies.
Source: International Congress 2018 – The world of idiopathic pulmonary fibrosis (IPF): global registries
Year: 2018
Anti-endothelial cell antibodies in patients with COPD
Source: Eur Respir J 2007; 30: Suppl. 51, 56s
Year: 2007
Nine cases of interstitial lung disease associated with anti-CADM140 antibody positive dermatomyositis
Source: Annual Congress 2012 - Diffuse parenchymal lung disease: clinical profiles and collagen vascular disease
Year: 2012
Anti-parietal cell autoimmunity in IPF patients
Source: International Congress 2016 – IPF: from pathogenesis to treatment I
Year: 2016
Anti-endothelial cell antibodies in idiopathic pulmonary arterial hypertension
Source: Eur Respir J 2006; 28: Suppl. 50, 339s
Year: 2006
Utility of myositis related antibodies in interstitial lung disease and suspected autoimmunity.
Source: International Congress 2019 – From biomarkers to treatment of immune-mediated interstitial lung disease: what’s new?
Year: 2019
Myositis-specific antibodies identify a distinct interstitial pneumonia with autoimmune features phenotype
Source: Eur Respir J, 56 (6) 2001205; 10.1183/13993003.01205-2020
Year: 2020
Distinctive polarization of circulating classical monocytes between idiopathic pulmonary fibrosis and idiopathic nonspecific interstitial pneumonia.
Source: Virtual Congress 2020 – Biomarkers and mechanistic aspects of idiopathic pulmonary fibrosis
Year: 2020
Cyclophosphamide in steroid refractory unclassifiable idiopathic interstitial pneumonia and interstitial pneumonia with autoimmune features (IPAF)
Source: Eur Respir J, 51 (4) 1702519; 10.1183/13993003.02519-2017
Year: 2018
Evaluation of interstitial inflammatory cell in idiopathic interstitial pneumonias
Source: Eur Respir J 2006; 28: Suppl. 50, 99s
Year: 2006
Survival of patients with biopsy-proven usual interstitial pneumonia and nonspecific interstitial pneumonia
Source: Eur Respir J 2002; 19: 1114-1118
Year: 2002
Clinico-radiological-pathological features of MPO-ANCA-positive interstitial pneumonia
Source: Annual Congress 2007 - Miscellaneous interstitial lung diseases related to systemic and other diseases
Year: 2007
Interstitial lung disease in an adult patient with dermatomyositis and anti-NXP2 autoantibody
Source: Eur Respir Rev 2015; 24: 370-372
Year: 2015
Clinical and pathological findings of patients with interstitial lung diseases associated with antisynthetase other than Jo-1 antibodies
Source: Eur Respir J 2005; 26: Suppl. 49, 541s
Year: 2005
Characterisation of patients with interstitial pneumonia with autoimmune features
Source: Eur Respir J 2016; 47:1767-1775
Year: 2016
The classification, natural history and radiological/histological appearance of idiopathic pulmonary fibrosis and the other idiopathic interstitial pneumonias
Source: Eur Respir Rev 2008; 17: 108-115
Year: 2008
Prognosis of pulmonary fibrosis with usual interstitial pneumonia pattern in myeloperoxidase anti-neutrophil cytoplasmic autoantibody-related nephritiss
Source: International Congress 2018 – Idiopathic interstital pneumonias other than idiopathic pulmonary fibrosis (IPF)
Year: 2018
Autoantibodies in patients with idiopathic pulmonary fibrosis
Source: International Congress 2019 – Interstitial lung disease registries
Year: 2019
Suboptimal treatment response to anti-IL-5 monoclonal antibodies in severe eosinophilic asthmatics with airway autoimmune phenomena
Source: Eur Respir J, 56 (4) 2000117; 10.1183/13993003.00117-2020
Year: 2020
Clinical significance of histological classification of idiopathic interstitial pneumonia
Source: Eur Respir J 2002; 19: 275-283
Year: 2002
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept